Home › Onyx confirms, rejects Amgen's $120-per-share bid
 

Keywords :   


Onyx confirms, rejects Amgen's $120-per-share bid

2013-06-30 21:11:06| Biotech - Topix.net

Onyx Pharmaceuticals Inc. on Sunday confirmed that it received an unsolicited takeover bid from Amgen Inc. for $120 per share.

Tags: bid confirms rejects onyx

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
25.11 24.525.5cm
25.11 B
25.11SHIMANO CS-R8000 14-28t 1
25.11RADWIMPS/
25.11Delegation Delegation
25.11009 19685DVD
25.1124 C2000S
25.11stayc applemusic so bad 1
More »